Veterinary Research Communications

, Volume 16, Issue 2, pp 131–138 | Cite as

The pharmacokinetics of a slow-release theophylline preparation in horses after intravenous and oral administration

  • J. O. Errecalde
  • M. F. Landoni


The pharmacokinetics of a slow-release theophylline formulation was investigated following intravenous and oral administration at 10 mg/kg in horses. A tricompartmental model was selected to describe the intravenous plasma profile. The elimination half-life (t1/2β) was 16.91 ± 0.93 h, the apparent volume of distribution (Vd) was 1.35 ± 0.18 L/kg and the body clearance (ClB) was 0.061 ± 0.009 L kg−1 h. After oral administration the half-life of absorption was 1.24 ± 0.30 h, and the calculated bioavailability was above 100%. Thet1/2β after oral administration was 18.51 ± 1.75 h, only a little longer than that after intravenous administration. The slow release formulation did not exhibit any advantage in prolonging thet1/2β of theophylline in the horse.


horses pharmacokinetics slow release formulation theophylline 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Akaike, H., 1976. An information criterion (AIC).Mathematical Science,14, 5–9Google Scholar
  2. Ayres, J., Pearson, E., Riebold, T. and Chang, S., 1985. Theophylline and diphylline pharmacokinetics in the horse.American Journal of Veterinary Research,46, 2500–2506PubMedGoogle Scholar
  3. Beech, H., 1979. Principles of therapy.Veterinary Clinics of North America. Large Animals Practice,1, 73–88Google Scholar
  4. D'Argenio, D. and Schumitzky, A., 1979. A program package for simulation and parameter estimation in pharmacokinetic systems.Computer Programs in Biomedicine,9, 115–134PubMedGoogle Scholar
  5. Davis, L.E., 1980. Applied pharmacodynamics of digitalis, theophylline, diuretics and selected antiarrythmics drugs. In: R.W. Kirk (ed),Current Veterinary Therapy VII. Small Animal Practice, (W.B. Saunders, Philadelphia), 352–359Google Scholar
  6. Davis, L.E., Neff Davis, C., Koritz, G.D., Bevill, R.F., Sharma, G.C., Langston, V.C. and Munsiff, I.J., 1987. Effect of organic vehicles in pharmacokinetics of aminophylline administered intravenously to goats.Journal of Veterinary Pharmacology and Therapeutics,10, 144–149PubMedGoogle Scholar
  7. Derksen, F.J., 1983. Chronic airway disease. In: E. Robinson (ed),Current Therapy in Equine Medicine, (W.B. Saunders, Philadelphia), 509Google Scholar
  8. Errecalde, J.O., Button, C., Baggot, J.D. and Mulders, M.S.G., 1984. Pharmacokinetics and bioavailability of theophylline in horses.Journal of Veterinary Pharmacology and Therapeutics,7, 255–264PubMedGoogle Scholar
  9. Hendeles, L. and Weinberger, M., 1982. Improved efficacy and safety of theophylline in the control of airways hyperactivity.Annals of Allergy,49, 247–256PubMedGoogle Scholar
  10. Ingvast-Larson, C., Paalzow, L., Ottosson, T. and Appelgreen, L.E., 1985. Pharmacokinetic studies of theophylline in horses.Journal of Veterinary Pharmacology and Therapeutics,8, 76–81PubMedGoogle Scholar
  11. Jacobs, M.H., Senior, R.M. and Kessler, G., 1976. Clinical experience with theophylline: relationship between dosage, serum concentration and toxicity.Journal of the American Medical Association,235, 1983–1986PubMedGoogle Scholar
  12. Jenne, J.W., Wyze, E., Rood, F.S. and McDonald, F.M., 1972. Pharmacokinetics of theophylline: application to adjustment of the clinical dose of theophylline.Clinical Pharmacology and Therapeutics,13, 349–360PubMedGoogle Scholar
  13. Koritz, G., Borne, D., Hunt, J. and Prasad, V., 1981. Pharmacokinetics of theophylline in swine: a potential model for human drug bioavailability studies.Journal of Veterinary Pharmacology and Therapeutics,4, 233–239PubMedGoogle Scholar
  14. Koritz, G., McKiernan, B. and Neff Davies, C., 1986. Bioavailability of four slow release formulations in the Beagle dog.Journal of Veterinary Pharmacology and Therapeutics,9, 293–302PubMedGoogle Scholar
  15. Kowalczyk, D.F., Beech, J. and Littlejohn, D., 1984. Pharmacokinetic disposition of theophylline in horses after intravenous administration.American Journal of Veterinary Research,45, 2272–2275PubMedGoogle Scholar
  16. McKiernan, B.C. and Koritz, G.D., 1990. Plasma theophylline concentration and lung function in ponies with recurrent obstructive lung disease.Equine Veterinary Journal,22, 194–197PubMedGoogle Scholar
  17. McKiernan, B.C., Neff Davis, C., Koritz, G.D. and Pheris, D., 1981. Pharmacokinetic studies of theophylline in dogs.Journal of Veterinary Pharmacology and Therapeutics,4, 103–110PubMedGoogle Scholar
  18. McKiernan, B.C., Koritz, G.D., Davis, E. and Munsiff, I., 1983. Pharmacokinetic studies of theophylline in cats.Journal of Veterinary Pharmacology and Therapeutics,6, 99–104PubMedGoogle Scholar
  19. Mitenko, P. and Ogilvie, R., 1973. Rational intravenous doses of theophylline.New England Journal of Medicine,289, 600–603PubMedGoogle Scholar
  20. Nelder, J. and Mead, R., 1965. A simplex method for function minimization.Computers Journal,4, 300–313Google Scholar
  21. Pollock, J., Kiechel, F., Cooper, D. and Weinberger, M., 1977. Relationship of serum theophylline concentration to inhibition of exercise induced bronchospasm and comparison with chromolyn.Pediatrics Springfield,60, 840–844Google Scholar
  22. Rall, T.W., 1980. The xanthines. In: A.G. Gilman, L.S. Goodman and A. Gilman (eds),The Pharmacological Basis of Therapeutics, 6th edn, (McMillan, New York), 592–607Google Scholar
  23. Short, C.R., Horner, M.W., Blay, P.K., Moss, M.S., Edington, N. and Clarke, C.R., 1986. The lack of effect of inoculation with equine influenza vaccine on theophylline pharmacokinetics in the horse.Journal of Veterinary Pharmacology and Therapeutics,9, 426–432PubMedGoogle Scholar
  24. Thomson, J.R. and McPherson, E.A., 1983. Chronic obstructive pulmonary disease in the horse 2: Therapy.Equine Veterinary Journal,15, 207–210PubMedGoogle Scholar
  25. Wade, A., 1977. InMartindale, The Extra Pharmacopoeia, 27th edn, (Pharmaceutical Press, London)Google Scholar
  26. Wagner, J.G., 1983.Farmacocinética Clínica, (Reverté, Barcelona, Spain), 175–232Google Scholar
  27. Yamaoka, K., Nakagawa, T. and Uno, T., 1978. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.Journal of Pharmacokinetics and Biopharmaceutics,6, 165–175PubMedGoogle Scholar
  28. Ziment, I., 1978. Phosphodiesterase inhibitors.Respiratory Pharmacology and Therapeutics, (W.B. Saunders, Philadelphia), 190–207Google Scholar

Copyright information

© Kluwer Academic Publishers bv 1992

Authors and Affiliations

  • J. O. Errecalde
    • 1
  • M. F. Landoni
    • 1
  1. 1.Cátedra de Farmacología, Facultad de Ciencias VeterinariasUniversidad Nacional de La PlataLa PlataArgentina

Personalised recommendations